imiquimod has been researched along with Epidermodysplasia Verruciformis in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 9 (69.23) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Moore, S; Rady, P; Tyring, S | 1 |
| Brennand, S; Chong, AH; Fahey, V; Goh, MS; Maor, D; Tabrizi, SN | 1 |
| Hugh, JM; Nijhawan, RI; Osei-Tutu, A | 1 |
| Bravo, AI; Castro-Perez, GA; Mazzuoccolo, LD; Sorin, I | 1 |
| Cappel, M; Hoesly, F | 1 |
| Honda, M; Kato, T; Kawase, M; Mitsuishi, T; Yoshida, R | 1 |
| Acharya, S; Arumainayagam, JT; Dhesi, I; Kasparis, C; Lau, C | 1 |
| Caglia, M; Hashemi, P; Kim, C; Shulman, K | 1 |
| Bercovitch, L; Lee, KC; Risser, J | 1 |
| Heratizadeh, A; Kapp, A; Kupsch, E; Völker, B; Werfel, T; Wichmann, K | 1 |
| Adim, SB; Baskan, EB; Toker, S; Tunali, S; Turan, A | 1 |
| Berthelot, C; Dickerson, MC; He, Q; Niroomand, F; Pandya, AG; Rady, P; Tyring, SK | 1 |
| Houwing, RH; Janssen, K; Lucker, GP; van Rijssel, R | 1 |
3 review(s) available for imiquimod and Epidermodysplasia Verruciformis
| Article | Year |
|---|---|
Acquired epidermodysplasia verruciformis: clinical presentation and treatment update.
Topics: Acitretin; Cidofovir; Epidermodysplasia Verruciformis; HIV Infections; Humans; Imiquimod; Mycophenolic Acid; Papillomaviridae; Papillomavirus Infections; Vaccines | 2022 |
Flat-topped and condylomatous papules in a lung transplant patient.
Topics: Aminoquinolines; Biopsy, Needle; Combined Modality Therapy; Condylomata Acuminata; Cryotherapy; Diagnosis, Differential; Epidermodysplasia Verruciformis; Female; Follow-Up Studies; Humans; Imiquimod; Immunocompromised Host; Immunohistochemistry; Lung Transplantation; Middle Aged; Risk Assessment; Thigh; Transplantation Immunology; Treatment Outcome | 2014 |
[Successful symptomatic treatment of epidermodysplasia verruciformis with imiquimod 5% cream].
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Biopsy; Consanguinity; DNA Probes, HPV; Drug Administration Schedule; Drug Eruptions; Epidermodysplasia Verruciformis; Facial Dermatoses; Humans; Imiquimod; Male; Oligonucleotide Array Sequence Analysis; Papillomavirus Infections; Skin | 2010 |
10 other study(ies) available for imiquimod and Epidermodysplasia Verruciformis
| Article | Year |
|---|---|
A case of acquired epidermodysplasia verruciformis in a renal transplant recipient clearing with multimodal treatment including HPV (Gardasil) vaccination.
Topics: Acitretin; Adjuvants, Immunologic; Drug Therapy, Combination; Epidermodysplasia Verruciformis; Female; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; Humans; Imiquimod; Immunosuppression Therapy; Keratolytic Agents; Kidney Transplantation; Middle Aged; Tretinoin | 2018 |
Sustained clinical resolution of acquired epidermodysplasia verruciformis in an immunocompromised patient after discontinuation of oral acitretin with topical imiquimod.
Topics: Acitretin; Adjuvants, Immunologic; Administration, Cutaneous; Administration, Oral; Aminoquinolines; Epidermodysplasia Verruciformis; HIV Infections; Humans; Imiquimod; Immunocompromised Host; Keratolytic Agents; Male; Middle Aged; Treatment Outcome | 2013 |
Acquired epidermodysplasia verruciformis in a patient with congenital HIV infection.
Topics: Aminoquinolines; Antiretroviral Therapy, Highly Active; Biopsy; Cryosurgery; Electrocoagulation; Epidermodysplasia Verruciformis; HIV Infections; Humans; Imiquimod; Keratinocytes; Male; Tretinoin; Young Adult | 2013 |
Two sisters reveal autosomal recessive inheritance of epidermodysplasia verruciformis: a case report.
Topics: Adult; Alphapapillomavirus; Aminoquinolines; Antiviral Agents; Epidermodysplasia Verruciformis; Female; Fluorouracil; Genes, Recessive; Humans; Imiquimod; Membrane Proteins; Mutation; Siblings; Virion; Young Adult | 2014 |
Acquired epidermodysplasia verruciformis in an HIV-positive patient.
Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Antiretroviral Therapy, Highly Active; Epidermodysplasia Verruciformis; Female; HIV Infections; Humans; Imiquimod; Immunocompromised Host; Skin; Treatment Outcome | 2016 |
Treatment of Imiquimod Resistant Epidermodysplasia Verruciformis With Ingenol Mebutate.
Topics: Acitretin; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Diterpenes; Drug Resistance; Epidermodysplasia Verruciformis; Female; Gels; Humans; Imiquimod; Keratolytic Agents; Rare Diseases; Skin Neoplasms; Treatment Outcome; Tretinoin | 2016 |
What is the evidence for effective treatments of acquired epidermodysplasia verruciformis in HIV-infected patients?
Topics: Adjuvants, Immunologic; Adolescent; Aminoquinolines; Antiretroviral Therapy, Highly Active; Epidermodysplasia Verruciformis; HIV Infections; Humans; Imiquimod; Male; Treatment Outcome | 2010 |
A case of epidermodysplasia verruciformis associated with squamous cell carcinoma and Bowen's disease: a therapeutic challenge.
Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma, Squamous Cell; Diagnosis, Differential; Drug Therapy, Combination; Epidermodysplasia Verruciformis; Humans; Imiquimod; Interferons; Male; Middle Aged; Scalp; Skin Neoplasms | 2006 |
Treatment of a patient with epidermodysplasia verruciformis carrying a novel EVER2 mutation with imiquimod.
Topics: Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Epidermodysplasia Verruciformis; Humans; Imiquimod; Male; Membrane Proteins; Mutation; Skin Neoplasms | 2007 |
Epidermodysplasia verruciformis: unsuccessful therapeutic approach with imiquimod.
Topics: Aminoquinolines; Epidermodysplasia Verruciformis; Humans; Imiquimod; Male; Middle Aged; Treatment Failure | 2007 |